Refeyn

Activities: Manufacturing

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Analysis

Refeyn expands the analytical possibilities for high concentration samples by MassFluidix HC

New microfluidic system enhances protein analysis workflows for the study of weak protein-protein interactions by mass photometry
Manufacturing

Refeyn expands into AAV-based gene therapy manufacturing with GMP software

The manufacturer has deployed its new mass photometers, optimised for AAV analytics to provide accurate measurements of empty:full AAV ratios
Manufacturing

Refeyn launches SamuxMP Auto for automated AAV capsid analysis

New mass photometer characterises AAV sample purity and empty/full ratio, with less manual operation time and greater reproducibility
Subscribe now